Navigation Links
Risk of vibration-induced vascular injuries linked to vibration frequency differences
Date:4/19/2009

Speaking on April 19 at the Experimental Biology 2009 meeting in New Orleans, Dr. Kristine Krajnak, a team leader in the Engineering and Control Technologies Branch of the Health Effects Laboratory Division of NIOSH in Morgantown, West Virginia, describes results from the first study to directly link the different physical responses of tissue that occur with exposure to different vibration frequencies with biological mechanisms underlying the development of vascular dysfunction. Her presentation is part of the scientific program of The American Physiological Society.

The study, along with results of other studies conducted by NIOSH, supports the importance of reducing job-related exposure to vibration. Ongoing research is evaluating the effectiveness of anti-vibration devices, such as anti-vibration gloves and tools.

Higher frequency vibrations produced by an electric sander (greater than 100 Hz) are smoother than the slower vibrations of an electric hand drill (approximately 63 Hz) and therefore are less likely to cause users discomfort.

Don't let that fool you into not using protective devices that can reduce your exposure to vibration, she says. The new research study conducted at the National Institute for Occupational Safety and Health (NIOSH) suggests that exposure to high and low frequencies cause different physiological responses, but both may affect the risk of developing vibration-induced peripheral vascular dysfunction.

Of the 1.1 to 1.5 million U.S. workers exposed to hand transmitted vibration on a fairly regular basis, approximately half eventually develop some disorder such as Vibration White Finger, in which a single finger or sometimes the entire hand turns white and numb when exposed to the cold, due to restricted blood flow.

Workers also may experience reductions in tactile sensitivity, grip strength, and/or manual dexterity. Earlier studies have shown that risk goes up with frequency and dura
'/>"/>

Contact: Sylvia Wrobel
ebpress@gmail.com
770-722-0155
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Gender, coupled with diabetes, affects vascular disease development
2. Contribution of cholesterol transporter to vascular disease
3. Proposal to step up cardiovascular disease research
4. Fourth Annual International Conference on Cell Therapy for Cardiovascular Diseases
5. Top scientists meet for global conference on stem cell therapy for cardiovascular diseases
6. Medical breakthrough for organ transplants and cardiovascular diseases by Flemish researchers
7. Cell Therapy for Cardiovascular Diseases
8. $13 million federal grant for research into vascular disease awarded to Weill Cornell
9. Genetic variants of USF1 are associated with the increased risk for cardiovascular disease
10. Human vascular system in mice
11. New research shows no link between aromatase inhibitors and cardiovascular problems

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
(Date:11/25/2009)... Athens, Ga. Bacteria don,t have easy lives. In a...he bugs, they have natural enemies called bacterio...th every two days. , Still, bacteria and anothe...scovered in extreme environments such as deep-sea ...rt because they have a built-in defense system tha...
(Date:11/25/2009)... Over the course of a lifetime, the heart pumps so...n the order to do this, the muscle fibers of the h...oup headed by Dr. Wolfgang Rottbauer, vice chair o...versity Hospital (Chairman: Prof. Dr. H. A. Katus)... the stability of the smallest muscular unit, the ...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2CCMC Celebrates Case Management Week 28Oct 11 17 29 With Second Annual Patricia McCollom Scholarship 58859 1CCMC Celebrates Case Management Week 28Oct 11 17 29 With Second Annual Patricia McCollom Scholarship 58859 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 1Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 3Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 4Lincare Holdings Inc Extends Terms of Employment Agreements with Executive Officers 5219 1Lincare Holdings Inc Extends Terms of Employment Agreements with Executive Officers 5219 2
...quences from tiny green algae have provided new in...kton evolve—and further highlights their critical ...ese findings, by a group led by the DOE Joint Geno... Oceanography, University of California, San Diego...e published this week in the Proceedings of the Na...
... potentially assist cancer diagnosis, a new optica...ional images of blood vessels by taking advantage ...s of hemoglobin, the red-blood-cell molecule that ...earch will be presented in Baltimore at CLEO/QELS,...loped at Duke University, should provide 3-D image...
... Institute for Biological Studies have identified ...in healthy muscle and restores normal muscle funct...es. The study, published online in Nature Medicine...ys in a cascade of events triggered by exercise-in...cular pathway, a molecular switch turns on a set o...
Other Biology News:Puzzling plankton yield secrets to role in evolution/global photosynthesis 2Puzzling plankton yield secrets to role in evolution/global photosynthesis 3Catching cancer's spread by watching hemoglobin 2Catching cancer's spread by watching hemoglobin 3Salk scientists hammer out a pathway that promotes muscle cell survival in mice 2
(Date:11/24/2009)...New York investment bank KTA Capital,s client Neur...6.7 mil convertible note private placement with a ... was arranged by KTA Capital as Neuren,s exclusive... New York (PRWEB) November 23, 2009 -- The i...LC ("KTA Capital") has announced that it...
(Date:11/24/2009)... 24 Sigma-Aldrich Corpor...ASDAQ OMX conference on Tuesday, December 1st at 1...arties may listen via live audio broadcast over th... m a a ldrich.com/ . Users can click the "Web...gma-Aldrich: Sigma-Aldrich is a leading Life Sci...
(Date:11/24/2009)...if., Nov. 24 NeurogesX, ... focused on developing and commercializing novel p...hony DiTonno, President and Chief Executive Office...r Jaffray Health Care Conference, to be held Decem...York, New York. ,, Mr. DiTonno and Stephen Ghi...
(Date:11/24/2009)...cacy endpoint has been met for patients with advan..., QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - ...the "Company"), a global biopharmaceutical company...announced positive efficacy data from a Phase 2 st... AEZS-108 (formerly AN-152), in patients with adva...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...ektar Therapeutics,(Nasdaq: NKTR ) announced tod...,Directors effective January 23, 2009. Mr. Lerner...een a member of the Nektar Board of Directors,sinc... The Board of Directors and the Company wish t...s made by providing the benefit of his,extensive i...
...9 ThermoGenesis,Corp. (Nasdaq: KOOL ), a leadin... store adult stem cells, announced today it will r...ter ended December 31, 2008, on Wednesday, Februar...cast , Management will host a conference call ...00 PM Eastern) to review the fiscal second quarter...
...f Kingdee enterprise accounting system across its ...., Jan. 29 AMDL, Inc. (NYSE Alternext US: ADL), a... operations in China and the US, announced today i...enterprise accounting system across its US and Chi...sed Kingdee International Software, the new accoun...
Other Biology Technology:ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009 2AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 2AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 3AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 4
Propidium Iodide Buffer from BioLegend
Mouse Anti-Escherichia coli Lac1 Monoclonal Antibody, Unconjugated, Clone 0.T.81 from Abcam
Goat Anti-Human HADHB Polyclonal Antibody, Unconjugated from IMGENEX
EDG-6 Lysate from Exalpha Biologicals, Inc.
Biology Products: